logo

Eiger Biopharmaceuticals Inc. (EIGR)



Trade EIGR now with
  Date
  Headline
5/17/2018 7:18:44 AM Wedbush Reiterates Eiger BioPharmaceuticals Inc. (EIGR) At Outperform With $53 Up From $36 Price Target
5/9/2018 1:35:56 PM B. Riley FBR Starts Eiger BioPharmaceuticals Inc. (EIGR) At Buy With $24 Price Target
4/26/2018 10:25:25 AM Wedbush Reiterates Eiger BioPharmaceuticals Inc. (EIGR) At Outperform With $36 Price Target
3/22/2018 8:21:38 AM Wedbush Is Raising Eiger BioPharmaceuticals Inc. (EIGR) FY18 Estimate To -2.32 From -3.42
3/22/2018 8:21:21 AM Wedbush Is Increasing Eiger BioPharmaceuticals Inc. (EIGR) Q4 18 Estimate To -0.46 From -0.84
3/22/2018 8:20:58 AM Wedbush Is Increasing Eiger BioPharmaceuticals Inc. (EIGR) Q3 18 Estimate To -0.53 From -0.85
3/22/2018 8:20:45 AM Wedbush Is Raising Eiger BioPharmaceuticals Inc. (EIGR) Q2 18 Estimate To -0.61 From -0.86
3/22/2018 8:20:32 AM Wedbush Is Raising Eiger BioPharmaceuticals Inc. (EIGR) Q1 18 Estimate To -0.73 From -0.87
3/22/2018 8:19:59 AM Wedbush Reiterates Eiger BioPharmaceuticals Inc. (EIGR) At Outperform With $36 Up From $34 Price Target
1/16/2018 12:20:45 PM Wedbush Reiterates Eiger BioPharmaceuticals Inc. (EIGR) At Outperform With $34 Price Target
12/19/2017 6:30:37 AM Wedbush Is Raising Eiger BioPharmaceuticals Inc. (EIGR) 2018 Estimate To -3.42 From -5.14
12/19/2017 6:30:22 AM Wedbush Is Increasing Eiger BioPharmaceuticals Inc. (EIGR) Q4 18 Estimate To -0.84 From -1.28
12/19/2017 6:30:07 AM Wedbush Is Raising Eiger BioPharmaceuticals Inc. (EIGR) Q3 18 Estimate To -0.85 From -1.28
12/19/2017 6:29:53 AM Wedbush Is Increasing Eiger BioPharmaceuticals Inc. (EIGR) Q2 18 Estimate To -0.86 From -1.28
12/19/2017 6:29:39 AM Wedbush Is Raising Eiger BioPharmaceuticals Inc. (EIGR) Q1 18 Estimate To -0.87 From -1.29
12/19/2017 6:29:13 AM Wedbush Is Increasing Eiger BioPharmaceuticals Inc. (EIGR) 2017 Estimate To -3.88 From -5.22
12/19/2017 6:29:01 AM Wedbush Is Increasing Eiger BioPharmaceuticals Inc. (EIGR) Q4 17 Estimate To -0.88 From -1.25
10/25/2017 9:55:09 AM Wedbush Reiterates Eiger BioPharmaceuticals Inc. (EIGR) At Outperform With $34 Price Target
8/14/2017 9:50:48 AM Wedbush Reiterates Eiger BioPharmaceuticals Inc. (EIGR) At Ourperform With $34 Price Target
6/21/2017 7:07:10 AM Wedbush Is Lowering Eiger BioPharmaceuticals Inc. (EIGR) 2017 Estimate To -4.79 From -4.58